Lilly Wins Ruling Delaying Teva Bid To Market Generic Evista
CNNMoney.com
WASHINGTON -(Dow Jones)- A federal appeals court on Tuesday upheld a trial judge's decision to delay Teva Pharmaceutical Industries Ltd.'s (TEVA) bid to market a generic version of Eli Lilly & Co.'s (LLY) blockbuster osteoporosis drug Evista. …
Fed. Circ. Affirms Stay Extension In Evista Dispute IP Law360 (subscription)
Teva loses fight against Evista injunction Globes
all 7 news articles